Header Logo

Connection

Megan Lerner to Glioblastoma

This is a "connection" page, showing publications Megan Lerner has written about Glioblastoma.
Connection Strength

0.527
  1. XRN2 Is Required for Cell Motility and Invasion in Glioblastomas. Cells. 2022 04 28; 11(9).
    View in: PubMed
    Score: 0.187
  2. A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007. J Cell Mol Med. 2022 01; 26(2):570-582.
    View in: PubMed
    Score: 0.182
  3. Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model. J Cell Mol Med. 2020 01; 24(2):1738-1749.
    View in: PubMed
    Score: 0.159
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.